methyl 2-methoxybut-2-enoate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: methyl 2-methoxybut-2-enoate
• 化学式: C₆H₁₀O₃
• mdl: MFCD18973045
• 分子量: 130.14
• InChiKey: XDAOZDBTFSSMBW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  9
• 可旋转键数：
  3
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

文献信息

• Pyrido[2,3-b]indoles
  申请人：BEECHAM GROUP PLC

  公开号：EP0249301A1

  公开（公告）日：1987-12-16

  A compound of formula (I) or a pharmaceutically acceptable salt thereof: wherein: R, is hydrogen, C1-6 alkyl, phenyl or phenyl C1-4 alkyl wherein the phenyl moiety is optionally substituted by one or more C1-6 alkyl, C1-6 alkoxy, C1-6 alkylthio, hydroxy, C2-7 alkanoyl, halo, trifluoromethyl, nitro, amino optionally substituted by one or two C1-6 alkyl groups or by C2-7 alkanoyl, cyano, carbamoyl or carboxy groups; R2, R3 and R4 are independently selected from hydrogen, C1-6 alkyl, C1-6 alkoxy, C1-6 alkoxycarbonyl, C1-6 alkylthio, hydroxy, C2-7 alkanoyl, chloro, fluoro, trifluoromethyl, nitro, amino optionally substituted by one or two C1-6 alkyl groups or by C2-7 alkanoyl, cyano, carbamoyl and carboxy, and phenyl, phenyl C1-4 alkyl or phenyl C1-4, alkoxy in which any phenyl moiety is optionally substituted by any of these groups; R5 and R6 are independently selected from hydrogen, C1-6 alkyl, C3-7 cycloalkyl, C3-7 cycloalkyl-C1-4 alkyl, C2-6 alkenyl, C1-7 alkanoyl, C1-6 alkylsulphonyl, di-(C1-6 alkyl)amino C1-6 alkyl, 3-oxobutyl, 3-hydroxybutyl, phenyl, phenyl C1-4 alkyl, benzoyl, phenyl C2-7 alkanoyl or benzenesulphonyl any of which phenyl moieties are optionally substituted by one or two halogen, C1-6 alkyl, C1-8 alkoxy, CF3, amino or carboxy, or R6 and R6 together are C2-6 polymethylene optionally interrupted by oxygen or NR9 wherein R9 is hydrogen or C1-6 alkyl optionally substituted by hydroxy; R7 is hydrogen, C1-6 alkyl, C3-6 cycloalkyl, C3-6 cycloalkyl-C1-4 alkyl, C2-6 alkenyl or C2-6 alkynyl; and -CO2R8 is a pharamaceutically acceptable ester group, processes for its preparation and its use as a pharmaceutical.

  式 (I) 的化合物或其药学上可接受的盐： 其中 R，是氢、C1-6 烷基、苯基或苯基 C1-4 烷基，其中苯基任选被一个或多个 C1-6 烷基、C1-6 烷氧基、C1-6 烷硫基、羟基、C2-7 烷酰基、卤代、三氟甲基、硝基、任选被一个或两个 C1-6 烷基或 C2-7 烷酰基取代的氨基、氰基、氨基甲酰基或羧基取代； R2、R3 和 R4 独立选自氢、C1-6 烷基、C1-6 烷氧基、C1-6 烷氧羰基、C1-6 硫代烷基、羟基、C2-7 烷酰基、氯、氟、三氟甲基、硝基、任选被一个或两个 C1-6 烷基或 C2-7 烷酰基、氰基、氨基甲酰基和羧基取代的氨基，以及苯基、苯基 C1-4 烷基或苯基 C1-4 烷氧基，其中任何苯基分子任选被上述任一基团取代； 苯基、苯基 C1-4 烷基、苯甲酰基、苯基 C2-7 烷酰基或苯磺酰基，其中任何苯基可选择被一个或两个卤素、C1-6 烷基、C1-8 烷氧基、CF3、氨基或羧基取代，或 R6 和 R6 合在一起是可选择被氧或 NR9 中断的 C2-6 聚亚甲基，其中 R9 是氢或可选择被羟基取代的 C1-6 烷基； R7是氢、C1-6烷基、C3-6环烷基、C3-6环烷基-C1-4烷基、C2-6烯基或C2-6炔基；和 -CO2R8是法学上可接受的酯基，其制备工艺和作为药物的用途。
• Anxiolytic and antidepressant tetrahydrobenzothienopyridine derivatives
  申请人：BEECHAM GROUP PLC

  公开号：EP0327223A1

  公开（公告）日：1989-08-09

  Compounds of formula (I) or pharmaceutically acceptable salts thereof: wherein: R₁ is hydrogen, C₁₋₆ alkyl, phenyl or phenyl C₁₋₄ alkyl wherein the phenyl moiety is optionally substituted by one or more C₁₋₆ alkyl, C₁₋₆ alkoxy, C₁₋₆ alkylthio, hydroxy, C₂₋₇ alkanoyl, halo, trifluoromethyl, nitro, amino optionally substituted by one or two C₁₋₆ alkyl groups or by C₂₋₇ alkanoyl, cyano, carbamoyl or carboxy groups; R₂, R₃ and R₄ are independently selected from hydrogen, C₁₋₆ alkyl, C₁₋₆ alkoxycarbonyl, C₁₋₆ alkylthio, C₂₋₇ alkanoyl, trifluoromethyl, cyano, carbamoyl and carboxy, and phenyl or phenyl C₁₋₄ alkyl in which any phenyl moiety is optionally substituted by C₁₋₆ alkyl, C₁₋₆ alkoxy, C₁₋₆ alkoxycarbonyl, C₁₋₆ alkylthio, hydroxy, C₂₋₇ alkanoyl, chloro, fluoro, trifluoromethyl, nitro or amino optionally substituted by one or two C₁₋₆ alkyl groups or by C₂₋₇ alkanoyl, cyano, carbamoyl and carboxy; R₅ and R₆ are independently selected from hydrogen, C₁₋₆ alkyl, C₃₋₇ cycloalkyl, C₃₋₇ cycloalkyl-C₁₋₄ alkyl, C₂₋₆ alkenyl, C₁₋₇ alkanoyl, C₁₋₆ alkylsulphonyl, di-(C₁₋₆ alkyl)amino C₁₋₆ alkyl, 3-oxobutyl, 3-hydroxybutyl, phenyl, phenyl C₁₋₄ alkyl, benzoyl, phenyl C₂₋₇ alkanoyl or benzenesulphonyl any of which phenyl moieties are optionally substituted by one or two halogen, C₁₋₆ alkyl, C₁₋₆ alkoxy, CF₃, amino or carboxy, or R₅ and R₆ together are C₂₋₆ polymethylene optionally interrupted by oxygen or NR₈ wherein R₈ is hydrogen or C₁₋₆ alkyl optionally substituted by hydroxy; and -CO₂R₇ is a pharmaceutically acceptable ester group, are provided for use in the treatment or prophylaxis of CNS disorders, in particular anxiety or depression.

  式 (I) 的化合物或其药学上可接受的盐： 其中 R₁ 是氢、C₁₋₆ 烷基、苯基或苯基 C₁₋₄ 烷基，其中苯基任选被一个或多个 C₁₋₆ 烷基、C₁₋₆ 烷氧基、C₁₋₆ 烷硫基、羟基、C₂₋₇烷酰基、卤素取代、羟基、C₂₋₇烷酰基、卤代、三氟甲基、硝基、任选被一个或两个 C₁₋₆ 烷基或 C₂₋₇ 烷酰基、氰基、氨基甲酰基或羧基取代的氨基； R₂、R₃ 和 R₄ 独立选自氢、C₁₋₆ 烷基、C₁₋₆ 烷氧羰基、C₁₋₆ 烷硫基、C₂₋₇ 烷酰基、三氟甲基、氰基、氨基甲酰基和羧基，以及苯基或 C₁₋₄烷基，其中任何苯基可任选被 C₁₋₆烷基取代、C₁₋₆烷氧基、C₁₋₆烷氧羰基、C₁₋₆烷硫基、羟基、C₂₋₇烷酰基、氯、氟、三氟甲基、硝基或氨基任选取代的烷基、硝基或氨基，可任选被一个或两个 C₁₋₆烷基或 C₂₋₇ 烷酰基、氰基、氨基甲酰基和羧基取代； R₅ 和 R₆ 独立选自氢、C₁₋₆ 烷基、C₃₋₇ 环烷基、C₃₋₇ 环烷基-C₁₋₄ 烷基、C₂₋₆ 烯基、C₁₋₇烷酰基、C₁₋₆ 烷磺酰基、二（C₁₋₆ 烷基）氨基 C₁₋₆ 烷基、3-氧代丁基、3-羟基丁基、苯基、苯基 C₁₋₄ 烷基、苯甲酰基、苯基 C₂₋₇烷酰基或苯磺酰基，其中任何苯基可选择被一个或两个卤素、C₁₋₆烷基、C₁₋₆烷氧基、CF₃、氨基或羧基取代、或 R₅ 和 R₆ 合在一起是 C₂₋₆ 聚亚甲基，可选择被氧或 NR₈ 中断，其中 R₈ 是氢或 C₁₋₆ 烷基，可选择被羟基取代；和-CO₂R₇是药学上可接受的酯基，可用于治疗或预防中枢神经系统疾病，尤其是焦虑症或抑郁症。
• PARTICLES COMPRISING AMPHIPHILIC COPOLYMERS, HAVING A CROSS-LINKED SHELL DOMAIN AND AN INTERIOR CORE DOMAIN, USEFUL FOR PHARMACEUTICAL AND OTHER APPLICATIONS
  申请人：G.D. Searle & Co.

  公开号：EP0907666A1

  公开（公告）日：1999-04-14
• US4952584A
  申请人：——

  公开号：US4952584A

  公开（公告）日：1990-08-28
• US5093493A
  申请人：——

  公开号：US5093493A

  公开（公告）日：1992-03-03